Related Experiment Video
Updated: Aug 8, 2026

Application of Genetically Encoded Fluorescent Nitric Oxide (NO•) Probes, the geNOps, for Real-time Imaging of NO• Signals in Single Cells
Published on: March 16, 2017
[Activation of nucleus-independent signals triggered by N-methyl-N'-nitro-N- nitrosoguanidine]
Zheng Wang1, Gu-liang Wang, Jun Yang
1Department of Pathophysiology, College of Medicine, Zhejiang University, Hangzhou 310031, China.
Objective:
To study the effect of MNNG on inducement of non-targeted mutation and activation of several cellular signal transduction pathways, and to determine whether the activation of these signaling pathways was dependent on the DNA-damage.
Methods:
Vero cells were enucleated by discontinuous density centrifugation. The PKA activities were measured by enzyme-linked immunosorbent assay. The status of cell membrane receptors was studied with immunofluorescent staining and confocal microscopy.
Result:
In enucleated cytoplasts, MNNG-treatment increased PKA activity for about 2.3-fold in accordance with the 2.7-fold up-regulation of PKA activity in whole vero cells exposed to MNNG. The clustering of cell surface receptors of epidermal growth factor and tumor necrosis factor alpha was also observed in cells exposed to MNNG; this phenomenon was also found in enucleated cells.
Conclusion:
The results indicate that the initiation of signal cascades induced by low concentration of MNNG might be associated with its interaction with cell surface receptors and/or direct activation of related signal proteins but not its DNA damage.
Insights
N-methyl-N-nitro-N-nitrosoguanidine (MNNG) activates cell signaling pathways and receptor clustering independently of DNA damage. This suggests MNNG initiates cellular responses through direct interaction with cell surface receptors or signaling proteins.
Area of Science:
- Cell Biology
- Molecular Toxicology
- Signal Transduction
Background:
- N-methyl-N-nitro-N-nitrosoguanidine (MNNG) is a known mutagen.
- Cellular signal transduction pathways are crucial for cellular responses.
- The relationship between MNNG-induced DNA damage and signaling pathway activation requires further elucidation.
Purpose of the Study:
- To investigate the effect of MNNG on non-targeted mutations.
- To determine the impact of MNNG on cellular signal transduction pathways.
- To ascertain if MNNG-induced signaling pathway activation is DNA-damage dependent.
Main Methods:
- Enucleation of Vero cells via density centrifugation.
- Measurement of protein kinase A (PKA) activity using ELISA.
- Analysis of cell membrane receptor status via immunofluorescent staining and confocal microscopy.
Main Results:
- MNNG treatment significantly increased PKA activity in both enucleated cytoplasts and whole Vero cells.
- Clustering of epidermal growth factor and tumor necrosis factor alpha receptors was observed upon MNNG exposure.
- These receptor-mediated effects were also evident in enucleated cells, indicating independence from nuclear DNA.
Conclusions:
- Low-concentration MNNG-induced signal cascades may originate from interactions with cell surface receptors.
- Direct activation of signaling proteins by MNNG is a potential mechanism.
- The observed signaling pathway activation is likely independent of MNNG-induced DNA damage.
More Related Videos
07:38A General Method for Detecting Nitrosamide Formation in the In Vitro Metabolism of Nitrosamines by Cytochrome P450s
Published on: September 25, 2017
09:33Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
Related Concept Videos
Nuclear Localization Signals and Import
2° Amines to N-Nitrosamines: Reaction with NaNO2
Activation and Inactivation of G Proteins
GPCRs Regulate Adenylyl Cylase Activity
Two...
Nitric Oxide Signaling Pathway
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...